Key facts
- It has raised $157.9M across 8 recorded rounds; the latest was Later Stage VC ($147.0M) in May 2025.
- Notable investors include Capital Factory, Biofest Invest, Cleveland Clinic Ventures, Congressionally Directed Medical Research Programs, Southwest National Pediatric Device Innovation Consortium — 7 tracked in total.
- Vascular Perfusion Solutions has filed 8 Form Ds with the SEC since 2019, most recently May 2025 ($147.0M sold to 21 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 8 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Vascular Perfusion Solutions
Funding rounds
8 roundsAbout Vascular Perfusion Solutions
Developer of medical devices designed to preserve and resuscitate vascularized organs. The company's devices use oxygenated perfusion preservation and resuscitation technology to maintain tissues and organs, enabling healthcare providers to increase the viability of donated limbs and organs for transplantation.
- Sector
- Healthcare
- HQ
- San Antonio, TX, United States
- Founded
- 2016
- Employees
- 10
- Website
- vascularperfusion.solutions/
- Ownership
- Privately Held (backing)
Vascular Perfusion Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vascular Perfusion Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vascular Perfusion Solutions in its N-PORT filings yet. We sweep new filings monthly.